Olivier DUCHAMP, IMODI coordinator, co-author of “PDX-MI Minimal Information for Patient-Derived Tumor Xenograft Models” publication

OncoSNIPE® artificial intelligence project officially launched
31/10/2017
cc
IMODI helps an association which assists children with cancer! 
08/12/2017

Olivier DUCHAMP, IMODI coordinator, co-author of “PDX-MI Minimal Information for Patient-Derived Tumor Xenograft Models” publication

PDX-MI Minimal Information for Patient-Derived Tumor Xenograft Models

With the participation of IMODI consortium

Read full publication

Abstract
Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient’s tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. Cancer Res; 77(21); e62–66.
©2017 AACR.

Share this



Get connected!

IMODI is now present on the Twitter and LinkedIn networks.
Follow us on @IMODI_Cancer and www.linkedin.com/company/imodi-cancer